, raising hopes the body 's immune system could be trained to attack melanoma
breast and lung cancer
The team at Stanford University School of Medicine believe the laboratory-engineered antibodies could eradicate not only primary tumours
, raising hopes the body 's immune system could be trained to attack melanoma
and believes the novel therapeutic strategy could utilise the patient 's own immune system to defend against certain cancers
